Evaluation of Melatonin and Antioxidant Levels in the Serum of Breast Cancer Patients

Metabolites and antioxidants can be altered in patients with various diseases, particularly in those with cancer. This study aims to measure melatonin and total antioxidant levels in the serum of breast cancer patients and compare them with a healthy control group. Both groups had serum samples coll...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BioMed Target Journal 2024-05, Vol.2 (1), p.35-42
Hauptverfasser: Qadir, Amjad Mahmood, Karatepe, Arzu, Yazici, Ayşegül, Rashid, Rzgar Farooq, Koparir, Pelin, Omer, Rebaz A., Hama, Shamal R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 42
container_issue 1
container_start_page 35
container_title BioMed Target Journal
container_volume 2
creator Qadir, Amjad Mahmood
Karatepe, Arzu
Yazici, Ayşegül
Rashid, Rzgar Farooq
Koparir, Pelin
Omer, Rebaz A.
Hama, Shamal R.
description Metabolites and antioxidants can be altered in patients with various diseases, particularly in those with cancer. This study aims to measure melatonin and total antioxidant levels in the serum of breast cancer patients and compare them with a healthy control group. Both groups had serum samples collected at 2:00 a.m. and 9:00 a.m. Melatonin levels were determined using High-performance liquid chromatography (HPLC), while total antioxidant levels were assessed by Enzyme-linked immunosorbent assay (ELISA). Levels of melatonin and total antioxidants differed between the groups. In the control group, the levels of melatonin and total antioxidants were considerably greater compared to the diagnostic group, with a p-value of 0.001. Melatonin and total antioxidant levels were consistently greater at 2:00 than at 9:00. The maximum melatonin levels recorded in the diagnostic and control groups were 39.3 pg/mL and 65.9 pg/mL, respectively. Melatonin levels varied based on the age of the participants, with higher amounts observed in younger participants compared to older people in both groups. The BMI affected the levels of melatonin, with a greater BMI leading to elevated melatonin concentrations. The diagnostic group had a total antioxidant level of 39.3 pg/mL, while the control group had a level of 65.9 pg/mL. The elevated levels of melatonin and total antioxidants in the control group indicate a healthy status. The research demonstrated a significant correlation between melatonin and antioxidant levels in breast cancer patients, with reduced melatonin levels and total antioxidant levels in the diagnosed group. Elevated BMI was linked to reduced melatonin levels.
doi_str_mv 10.59786/bmtj.215
format Article
fullrecord <record><control><sourceid>doaj_cross</sourceid><recordid>TN_cdi_crossref_primary_10_59786_bmtj_215</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_d178ceec49b64d91b0492bc2484af01d</doaj_id><sourcerecordid>oai_doaj_org_article_d178ceec49b64d91b0492bc2484af01d</sourcerecordid><originalsourceid>FETCH-LOGICAL-c100d-a35b1421d71650b352452e9184804c5e77481f62de29e430c831d79aeb3c775e3</originalsourceid><addsrcrecordid>eNpNkE1LAzEQhoMoWGoP_oNcPWzN5yY51lK1UFHQnkM2mdUt26xk06L_3m0r4mmGd2Yehgeha0qm0ihd3lbbvJkyKs_QiJmSFFQwff6vv0STvt8QQjinXCszQuvF3rU7l5su4q7GT9C63MUmYhcDnsUh_2qCixmvYA9tj4dJ_gD8Cmm3PRzcJXB9xnMXPST8MoAg5v4KXdSu7WHyW8dofb94mz8Wq-eH5Xy2KjwlJBSOy2p4iwZFS0kqLpmQDAzVQhPhJSglNK1LFoAZEJx4zYdd46DiXikJfIyWJ27o3MZ-pmbr0rftXGOPQZferUu58S3YQJX2AF6YqhTB0IoIwyrPhBauJjQMrJsTy6eu7xPUfzxK7FGvPei1g17-A1hWbFA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Evaluation of Melatonin and Antioxidant Levels in the Serum of Breast Cancer Patients</title><source>DOAJ Directory of Open Access Journals</source><creator>Qadir, Amjad Mahmood ; Karatepe, Arzu ; Yazici, Ayşegül ; Rashid, Rzgar Farooq ; Koparir, Pelin ; Omer, Rebaz A. ; Hama, Shamal R.</creator><creatorcontrib>Qadir, Amjad Mahmood ; Karatepe, Arzu ; Yazici, Ayşegül ; Rashid, Rzgar Farooq ; Koparir, Pelin ; Omer, Rebaz A. ; Hama, Shamal R.</creatorcontrib><description>Metabolites and antioxidants can be altered in patients with various diseases, particularly in those with cancer. This study aims to measure melatonin and total antioxidant levels in the serum of breast cancer patients and compare them with a healthy control group. Both groups had serum samples collected at 2:00 a.m. and 9:00 a.m. Melatonin levels were determined using High-performance liquid chromatography (HPLC), while total antioxidant levels were assessed by Enzyme-linked immunosorbent assay (ELISA). Levels of melatonin and total antioxidants differed between the groups. In the control group, the levels of melatonin and total antioxidants were considerably greater compared to the diagnostic group, with a p-value of 0.001. Melatonin and total antioxidant levels were consistently greater at 2:00 than at 9:00. The maximum melatonin levels recorded in the diagnostic and control groups were 39.3 pg/mL and 65.9 pg/mL, respectively. Melatonin levels varied based on the age of the participants, with higher amounts observed in younger participants compared to older people in both groups. The BMI affected the levels of melatonin, with a greater BMI leading to elevated melatonin concentrations. The diagnostic group had a total antioxidant level of 39.3 pg/mL, while the control group had a level of 65.9 pg/mL. The elevated levels of melatonin and total antioxidants in the control group indicate a healthy status. The research demonstrated a significant correlation between melatonin and antioxidant levels in breast cancer patients, with reduced melatonin levels and total antioxidant levels in the diagnosed group. Elevated BMI was linked to reduced melatonin levels.</description><identifier>ISSN: 2960-1428</identifier><identifier>EISSN: 2960-1428</identifier><identifier>DOI: 10.59786/bmtj.215</identifier><language>eng</language><publisher>QAASPA Publisher</publisher><subject>breast cancer ; elisa ; hplc ; melatonin ; sleeping disorder ; total antioxidants</subject><ispartof>BioMed Target Journal, 2024-05, Vol.2 (1), p.35-42</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c100d-a35b1421d71650b352452e9184804c5e77481f62de29e430c831d79aeb3c775e3</cites><orcidid>0000-0002-3981-9748 ; 0000-0001-6837-4891 ; 0000-0002-4142-6118 ; 0000-0002-9678-1053 ; 0000-0002-0846-9888 ; 0000-0001-7150-9849 ; 0000-0001-7468-516X ; 0000-0001-6649-2130</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids></links><search><creatorcontrib>Qadir, Amjad Mahmood</creatorcontrib><creatorcontrib>Karatepe, Arzu</creatorcontrib><creatorcontrib>Yazici, Ayşegül</creatorcontrib><creatorcontrib>Rashid, Rzgar Farooq</creatorcontrib><creatorcontrib>Koparir, Pelin</creatorcontrib><creatorcontrib>Omer, Rebaz A.</creatorcontrib><creatorcontrib>Hama, Shamal R.</creatorcontrib><title>Evaluation of Melatonin and Antioxidant Levels in the Serum of Breast Cancer Patients</title><title>BioMed Target Journal</title><description>Metabolites and antioxidants can be altered in patients with various diseases, particularly in those with cancer. This study aims to measure melatonin and total antioxidant levels in the serum of breast cancer patients and compare them with a healthy control group. Both groups had serum samples collected at 2:00 a.m. and 9:00 a.m. Melatonin levels were determined using High-performance liquid chromatography (HPLC), while total antioxidant levels were assessed by Enzyme-linked immunosorbent assay (ELISA). Levels of melatonin and total antioxidants differed between the groups. In the control group, the levels of melatonin and total antioxidants were considerably greater compared to the diagnostic group, with a p-value of 0.001. Melatonin and total antioxidant levels were consistently greater at 2:00 than at 9:00. The maximum melatonin levels recorded in the diagnostic and control groups were 39.3 pg/mL and 65.9 pg/mL, respectively. Melatonin levels varied based on the age of the participants, with higher amounts observed in younger participants compared to older people in both groups. The BMI affected the levels of melatonin, with a greater BMI leading to elevated melatonin concentrations. The diagnostic group had a total antioxidant level of 39.3 pg/mL, while the control group had a level of 65.9 pg/mL. The elevated levels of melatonin and total antioxidants in the control group indicate a healthy status. The research demonstrated a significant correlation between melatonin and antioxidant levels in breast cancer patients, with reduced melatonin levels and total antioxidant levels in the diagnosed group. Elevated BMI was linked to reduced melatonin levels.</description><subject>breast cancer</subject><subject>elisa</subject><subject>hplc</subject><subject>melatonin</subject><subject>sleeping disorder</subject><subject>total antioxidants</subject><issn>2960-1428</issn><issn>2960-1428</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpNkE1LAzEQhoMoWGoP_oNcPWzN5yY51lK1UFHQnkM2mdUt26xk06L_3m0r4mmGd2Yehgeha0qm0ihd3lbbvJkyKs_QiJmSFFQwff6vv0STvt8QQjinXCszQuvF3rU7l5su4q7GT9C63MUmYhcDnsUh_2qCixmvYA9tj4dJ_gD8Cmm3PRzcJXB9xnMXPST8MoAg5v4KXdSu7WHyW8dofb94mz8Wq-eH5Xy2KjwlJBSOy2p4iwZFS0kqLpmQDAzVQhPhJSglNK1LFoAZEJx4zYdd46DiXikJfIyWJ27o3MZ-pmbr0rftXGOPQZferUu58S3YQJX2AF6YqhTB0IoIwyrPhBauJjQMrJsTy6eu7xPUfzxK7FGvPei1g17-A1hWbFA</recordid><startdate>20240503</startdate><enddate>20240503</enddate><creator>Qadir, Amjad Mahmood</creator><creator>Karatepe, Arzu</creator><creator>Yazici, Ayşegül</creator><creator>Rashid, Rzgar Farooq</creator><creator>Koparir, Pelin</creator><creator>Omer, Rebaz A.</creator><creator>Hama, Shamal R.</creator><general>QAASPA Publisher</general><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-3981-9748</orcidid><orcidid>https://orcid.org/0000-0001-6837-4891</orcidid><orcidid>https://orcid.org/0000-0002-4142-6118</orcidid><orcidid>https://orcid.org/0000-0002-9678-1053</orcidid><orcidid>https://orcid.org/0000-0002-0846-9888</orcidid><orcidid>https://orcid.org/0000-0001-7150-9849</orcidid><orcidid>https://orcid.org/0000-0001-7468-516X</orcidid><orcidid>https://orcid.org/0000-0001-6649-2130</orcidid></search><sort><creationdate>20240503</creationdate><title>Evaluation of Melatonin and Antioxidant Levels in the Serum of Breast Cancer Patients</title><author>Qadir, Amjad Mahmood ; Karatepe, Arzu ; Yazici, Ayşegül ; Rashid, Rzgar Farooq ; Koparir, Pelin ; Omer, Rebaz A. ; Hama, Shamal R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c100d-a35b1421d71650b352452e9184804c5e77481f62de29e430c831d79aeb3c775e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>breast cancer</topic><topic>elisa</topic><topic>hplc</topic><topic>melatonin</topic><topic>sleeping disorder</topic><topic>total antioxidants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Qadir, Amjad Mahmood</creatorcontrib><creatorcontrib>Karatepe, Arzu</creatorcontrib><creatorcontrib>Yazici, Ayşegül</creatorcontrib><creatorcontrib>Rashid, Rzgar Farooq</creatorcontrib><creatorcontrib>Koparir, Pelin</creatorcontrib><creatorcontrib>Omer, Rebaz A.</creatorcontrib><creatorcontrib>Hama, Shamal R.</creatorcontrib><collection>CrossRef</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>BioMed Target Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Qadir, Amjad Mahmood</au><au>Karatepe, Arzu</au><au>Yazici, Ayşegül</au><au>Rashid, Rzgar Farooq</au><au>Koparir, Pelin</au><au>Omer, Rebaz A.</au><au>Hama, Shamal R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of Melatonin and Antioxidant Levels in the Serum of Breast Cancer Patients</atitle><jtitle>BioMed Target Journal</jtitle><date>2024-05-03</date><risdate>2024</risdate><volume>2</volume><issue>1</issue><spage>35</spage><epage>42</epage><pages>35-42</pages><issn>2960-1428</issn><eissn>2960-1428</eissn><abstract>Metabolites and antioxidants can be altered in patients with various diseases, particularly in those with cancer. This study aims to measure melatonin and total antioxidant levels in the serum of breast cancer patients and compare them with a healthy control group. Both groups had serum samples collected at 2:00 a.m. and 9:00 a.m. Melatonin levels were determined using High-performance liquid chromatography (HPLC), while total antioxidant levels were assessed by Enzyme-linked immunosorbent assay (ELISA). Levels of melatonin and total antioxidants differed between the groups. In the control group, the levels of melatonin and total antioxidants were considerably greater compared to the diagnostic group, with a p-value of 0.001. Melatonin and total antioxidant levels were consistently greater at 2:00 than at 9:00. The maximum melatonin levels recorded in the diagnostic and control groups were 39.3 pg/mL and 65.9 pg/mL, respectively. Melatonin levels varied based on the age of the participants, with higher amounts observed in younger participants compared to older people in both groups. The BMI affected the levels of melatonin, with a greater BMI leading to elevated melatonin concentrations. The diagnostic group had a total antioxidant level of 39.3 pg/mL, while the control group had a level of 65.9 pg/mL. The elevated levels of melatonin and total antioxidants in the control group indicate a healthy status. The research demonstrated a significant correlation between melatonin and antioxidant levels in breast cancer patients, with reduced melatonin levels and total antioxidant levels in the diagnosed group. Elevated BMI was linked to reduced melatonin levels.</abstract><pub>QAASPA Publisher</pub><doi>10.59786/bmtj.215</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-3981-9748</orcidid><orcidid>https://orcid.org/0000-0001-6837-4891</orcidid><orcidid>https://orcid.org/0000-0002-4142-6118</orcidid><orcidid>https://orcid.org/0000-0002-9678-1053</orcidid><orcidid>https://orcid.org/0000-0002-0846-9888</orcidid><orcidid>https://orcid.org/0000-0001-7150-9849</orcidid><orcidid>https://orcid.org/0000-0001-7468-516X</orcidid><orcidid>https://orcid.org/0000-0001-6649-2130</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2960-1428
ispartof BioMed Target Journal, 2024-05, Vol.2 (1), p.35-42
issn 2960-1428
2960-1428
language eng
recordid cdi_crossref_primary_10_59786_bmtj_215
source DOAJ Directory of Open Access Journals
subjects breast cancer
elisa
hplc
melatonin
sleeping disorder
total antioxidants
title Evaluation of Melatonin and Antioxidant Levels in the Serum of Breast Cancer Patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T14%3A51%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-doaj_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20Melatonin%20and%20Antioxidant%20Levels%20in%20the%20Serum%20of%20Breast%20Cancer%20Patients&rft.jtitle=BioMed%20Target%20Journal&rft.au=Qadir,%20Amjad%20Mahmood&rft.date=2024-05-03&rft.volume=2&rft.issue=1&rft.spage=35&rft.epage=42&rft.pages=35-42&rft.issn=2960-1428&rft.eissn=2960-1428&rft_id=info:doi/10.59786/bmtj.215&rft_dat=%3Cdoaj_cross%3Eoai_doaj_org_article_d178ceec49b64d91b0492bc2484af01d%3C/doaj_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_doaj_id=oai_doaj_org_article_d178ceec49b64d91b0492bc2484af01d&rfr_iscdi=true